Pfizer’s $70 billion deal with the U.S. government is essentially a PAY-OFF, granting preferential treatment and helping Pfizer avoid accountability

Lance D Johnson
Pfizer’s $70 billion deal with the U.S. government is essentially a PAY-OFF, granting preferential treatment and helping Pfizer avoid accountability
Estimated read time 1 min read

(NaturalNews) As Pfizer basks in record-breaking profits from its COVID-19 vaccine—now the most lucrative pharmaceutical product in history—the company has quie…

Lance D Johnson

You May Also Like

More From Author